AAGAB | Alpha- and gamma-adaptin binding protein | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
ABHD10 | Abhydrolase domain containing 10 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACAT1 | Acetyl-CoA acetyltransferase 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACOT9 | Acyl-CoA thioesterase 9 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACYP1 | Acylphosphatase 1, erythrocyte (common) type | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADRM1 | Adhesion regulating molecule 1 | Predicted intracellular proteins
| | | | | Expressed in all |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AKAP10 | A kinase (PRKA) anchor protein 10 | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDOA | Aldolase A, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
AMD1 | Adenosylmethionine decarboxylase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAM | Basal cell adhesion molecule (Lutheran blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAT2 | Branched chain amino-acid transaminase 2, mitochondrial | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BTRC | Beta-transducin repeat containing E3 ubiquitin protein ligase | Predicted intracellular proteins
| | | | | Expressed in all |
C17orf70 | Chromosome 17 open reading frame 70 | Predicted intracellular proteins
| | | | | Expressed in all |
C1orf198 | Chromosome 1 open reading frame 198 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPNS1 | Calpain, small subunit 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CARD8 | Caspase recruitment domain family, member 8 | Predicted intracellular proteins
| | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CD164 | CD164 molecule, sialomucin | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD276 | CD276 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD5 | CD5 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD86 | CD86 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |